26/16-2 Hemostatic Drugs.Medicine Coagulation Factor Viii Produced Using Recombinant Dna Technology For The Treatment Of Patients With Hemophilia A Lyophilized Po-K (Lyophilisate) For Preparation. Solution For Intravenous Administration Of 1000 Iu In A Package With A Solution And A Kit For Administration, Medicine Coagulation Factor Viii Produced Using Recombinant Dna Technology For The Treatment Of Patients With Hemophilia A Lyophilized Solution (Lyophilisate) For Preparation. Solution For Intravenous Administration 500 Iu In A Package With A Solution And A Kit For Administration, Medicine Coagulation Factor Ix Plasmatic, For Patients With Hemophilia B Under The Age Of 6 Years, For Adult Patients With Intolerance To Lyophilized Por-K (Lyophilisate) For Preparation. Solution For Infusion (For Injection) (Solution For Intravenous Administration) 500 Iu, Medicine Coagulation Factor Ix Plasmatic, For Patients With Hemophilia B Under The Age Of 6 Years, For Adult Patients With Intolerance To Lyophilized Por-K (Lyophilisate) For Preparation. Solution For Infusion (For Injection) (Solution For Intravenous Administration) 1000 Iu
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
